BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eriksson KF, Lindgärde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise. Diabetologia. 1998;41:1010-1016. [PMID: 9754818 DOI: 10.1007/s001250051024] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee-ødegård S, Olsen T, Norheim F, Drevon CA, Birkeland KI. Potential Mechanisms for How Long-Term Physical Activity May Reduce Insulin Resistance. Metabolites 2022;12:208. [DOI: 10.3390/metabo12030208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kawa LB. Evidence in Primary Prevention of Type 2 Diabetes Mellitus—What It Means for Primary Prevention of Type 2 Diabetes Mellitus Epidemic in Papua New Guinea. JDM 2022;12:87-97. [DOI: 10.4236/jdm.2022.122009] [Reference Citation Analysis]
3 Loeffelholz CV, Roth J, Coldewey SM, Birkenfeld AL. The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. Biomedicines 2021;9:1853. [PMID: 34944668 DOI: 10.3390/biomedicines9121853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Albaugh VL, Kindel TL, Nissen SE, Aminian A. Cardiovascular Risk Reduction Following Metabolic and Bariatric Surgery. Surg Clin North Am 2021;101:269-94. [PMID: 33743969 DOI: 10.1016/j.suc.2020.12.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Sciberras J, Camilleri LM, Cuschieri S. The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review. J Diabetes Metab Disord 2020;:1-9. [PMID: 33102262 DOI: 10.1007/s40200-020-00656-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science. Exp Biol Med (Maywood) 2020;245:889-96. [PMID: 32212859 DOI: 10.1177/1535370220915644] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
7 Regidor E, Albaladejo R, Mateo A, de la Fuente L, Barrio G, Ortega P. Macroeconomic fluctuations, changes in lifestyles and mortality from diabetes: a quasiexperimental study. J Epidemiol Community Health 2019;73:317-23. [PMID: 30700493 DOI: 10.1136/jech-2018-211464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Pedersen BK. Physical Exercise in Chronic Diseases. Nutrition and Skeletal Muscle. Elsevier; 2019. pp. 217-66. [DOI: 10.1016/b978-0-12-810422-4.00014-2] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Uusitupa M, Lindström J, Tuomilehto J. Prevention of type 2 diabetes-success story that is waiting for next steps. Eur J Clin Nutr 2018;72:1260-6. [PMID: 30185842 DOI: 10.1038/s41430-018-0223-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
10 Nielsen ML, Pareek M, Leósdóttir M, Eriksson K, Nilsson PM, Olsen MH. One-hour glucose value as a long-term predictor of cardiovascular morbidity and mortality: the Malmö Preventive Project. European Journal of Endocrinology 2018;178:225-36. [DOI: 10.1530/eje-17-0824] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 Sato Y, Nagasaki M, Nakai N, Fushimi T. Physical Exercise Improves Glucose Metabolism in Lifestyle-Related Diseases. Exp Biol Med (Maywood) 2016;228:1208-12. [DOI: 10.1177/153537020322801017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 8.8] [Reference Citation Analysis]
12 Lau CJ, Pisinger C, Husemoen LLN, Jacobsen RK, Linneberg A, Jørgensen T, Glümer C. Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine 2016;91:172-9. [DOI: 10.1016/j.ypmed.2016.08.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
13 Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25 Suppl 3:1-72. [PMID: 26606383 DOI: 10.1111/sms.12581] [Cited by in Crossref: 1405] [Cited by in F6Publishing: 1567] [Article Influence: 234.2] [Reference Citation Analysis]
14 Danielsson P, Truedsson L, Eriksson K, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med 2005;10:191-8. [DOI: 10.1191/1358863x05vm617oa] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
15 Watts S, Howard JY. Prediabetes: What Nurses Need to Know. Am J Nurs 2016;116:54-8. [PMID: 27336992 DOI: 10.1097/01.NAJ.0000484939.70970.c9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Fianu A, Bourse L, Naty N, Le Moullec N, Lepage B, Lang T, Favier F. Long-Term Effectiveness of a Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes in a Low Socio-Economic Community--An Intervention Follow-Up Study on Reunion Island. PLoS One 2016;11:e0146095. [PMID: 26731676 DOI: 10.1371/journal.pone.0146095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
17 Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:437-451. [PMID: 26167912 DOI: 10.7326/m15-0452] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 26.7] [Reference Citation Analysis]
18 Yılmaz S, Unal B. Effectiveness of nutrition and physical activity interventions in women with impaired fasting glucose: A randomized controlled trial in the community/Bozulmuş Açlık Glukozu Görülen Kadınlarda Beslenme ve Fiziksel Aktiviteye Yönelik Girişimlerinin Etkinliğ. Türkiye Halk Sağlığı Dergisi 2015;11:23-23. [DOI: 10.20518/tjph.173074] [Reference Citation Analysis]
19 Hussain N. Implications of using HBA1C as a diagnostic marker for diabetes. Diabetol Int 2016;7:18-24. [PMID: 30603239 DOI: 10.1007/s13340-015-0244-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Liu AY, Silvestre MP, Poppitt SD. Prevention of type 2 diabetes through lifestyle modification: is there a role for higher-protein diets? Adv Nutr 2015;6:665-73. [PMID: 26567192 DOI: 10.3945/an.115.008821] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
21 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 258] [Article Influence: 34.7] [Reference Citation Analysis]
22 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res. 2014;11:133-173. [PMID: 24800783 DOI: 10.1177/1479164114525548] [Cited by in Crossref: 131] [Cited by in F6Publishing: 146] [Article Influence: 18.7] [Reference Citation Analysis]
23 Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The Lancet Diabetes & Endocrinology 2014;2:474-80. [DOI: 10.1016/s2213-8587(14)70057-9] [Cited by in Crossref: 418] [Cited by in F6Publishing: 439] [Article Influence: 52.3] [Reference Citation Analysis]
24 Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Češka R, Corsini A, Erbel R, Flynn PD, Garcia-moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, Marques da Silva P, Masana L, Odawara M, Pedersen TR, Rotella CM, Salti I, Teramoto T, Tokgozoglu L, Toth PP, Valensi P, Vergès B. The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice. Atherosclerosis Supplements 2014;15:1-15. [DOI: 10.1016/j.atherosclerosissup.2014.04.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 78] [Article Influence: 8.6] [Reference Citation Analysis]
25 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes H, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Sousa Uva M, Taskinen M, Tendera M, Tuomilehto J, Valensi P, Luis Zamorano J, Luis Zamorano J, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol Ç, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Anton Sirnes P, Luis Tamargo J, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Anton Sirnes P, Alegria Ezquerra E, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Ž, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Luis Tamargo J, Viigimaa M, Vlachopoulos C, Xuereb RG; Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Revista Española de Cardiología 2014;67:136.e1-136.e56. [DOI: 10.1016/j.recesp.2013.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Khan UI, Rieder J, Cohen HW, Coupey SM, Wildman RP. Effect of modest changes in BMI on cardiovascular disease risk markers in severely obese, minority adolescents. Obes Res Clin Pract 2010;4:e163-246. [PMID: 24345667 DOI: 10.1016/j.orcp.2010.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
27 Hornnes P, Lauenborg J. Screening for Gestational Diabetes. Obesity 2013. [DOI: 10.1016/b978-0-12-416045-3.00020-0] [Reference Citation Analysis]
28 Haslam D. Weight control: key to managing ‘diabesity’. Diabetes & Vascular Disease 2013;13:7-12. [DOI: 10.1177/1474651412471689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Rydén L, Mellbin L. Glucose perturbations and cardiovascular risk: challenges and opportunities. Diab Vasc Dis Res 2012;9:170-6. [PMID: 22752941 DOI: 10.1177/1479164112451581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
30 Mensink M. Lifestyle intervention, glucose tolerance, and risk of developing type 2 diabetes mellitus. Metab Syndr Relat Disord 2005;3:26-34. [PMID: 18370707 DOI: 10.1089/met.2005.3.26] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
31 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
32 Jenkins NT, Hagberg JM. Aerobic training effects on glucose tolerance in prediabetic and normoglycemic humans. Med Sci Sports Exerc 2011;43:2231-40. [PMID: 21606871 DOI: 10.1249/MSS.0b013e318223b5f9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
33 Caterson ID, Finer N, Coutinho W, Van Gaal LF, Maggioni AP, Torp-pedersen C, Sharma AM, Legler UF, Shepherd GM, Rode RA, Perdok RJ, Renz CL, James WPT; on behalf of the SCOUT Investigators. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes, Obesity and Metabolism 2012;14:523-30. [DOI: 10.1111/j.1463-1326.2011.01554.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 10.8] [Reference Citation Analysis]
34 Nilsson PM. Hypertension, Obesity, and Metabolic Syndrome. Special Issues in Hypertension 2012. [DOI: 10.1007/978-88-470-2601-8_11] [Reference Citation Analysis]
35 Palmer AJ, Tucker DM. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Prim Care Diabetes 2012;6:109-21. [PMID: 22153888 DOI: 10.1016/j.pcd.2011.10.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
36 Lin CC, Li CI, Liu CS, Lin WY, Fuh MM, Yang SY, Lee CC, Li TC. Impact of lifestyle-related factors on all-cause and cause-specific mortality in patients with type 2 diabetes: the Taichung Diabetes Study. Diabetes Care 2012;35:105-12. [PMID: 22124717 DOI: 10.2337/dc11-0930] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
37 Chiasson J, Bernard S. Reducing cardiovascular risk factors in patients with prediabetes. Diabetes Management 2011;1:423-438. [DOI: 10.2217/dmt.11.28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Tuomilehto J, Schwarz P, Lindström J. Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care 2011;34 Suppl 2:S210-4. [PMID: 21525457 DOI: 10.2337/dc11-s222] [Cited by in Crossref: 118] [Cited by in F6Publishing: 129] [Article Influence: 10.7] [Reference Citation Analysis]
39 Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011;34 Suppl 2:S184-90. [PMID: 21525453 DOI: 10.2337/dc11-s216] [Cited by in Crossref: 229] [Cited by in F6Publishing: 250] [Article Influence: 20.8] [Reference Citation Analysis]
40 Fujii H, Yamamoto S, Takeda-imai F, Inoue M, Tsugane S, Kadowaki T, Noda M. Validity and applicability of a simple questionnaire for the estimation of total and domain-specific physical activity. Diabetol Int 2011;2:47-54. [DOI: 10.1007/s13340-011-0025-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
41 Uusitupa M, Tuomilehto J, Puska P. Are we really active in the prevention of obesity and type 2 diabetes at the community level? Nutr Metab Cardiovasc Dis 2011;21:380-9. [PMID: 21470836 DOI: 10.1016/j.numecd.2010.12.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
42 Longenberger A, Lim JY, Brown TT, Abraham A, Palella FJ, Effros RB, Orchard T, Brooks MM, Kingsley LA. Low physical function as a risk factor for incident diabetes mellitus and insulin resistance. Future Virol 2011;6:439-49. [PMID: 23805163 DOI: 10.2217/fvl.11.15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
43 Ramachandran A, Snehalatha C. Diabetes prevention programs. Med Clin North Am 2011;95:353-72, viii. [PMID: 21281838 DOI: 10.1016/j.mcna.2010.11.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
44 Saadi H, Al-Kaabi J, Benbarka M, Khalili A, Almahmeed W, Nagelkerke N, Abdel-Wareth L, Al Essa A, Yasin J, Al-Dabbagh B, Kazam E. Prevalence of undiagnosed diabetes and quality of care in diabetic patients followed at primary and tertiary clinics in Abu Dhabi, United Arab Emirates. Rev Diabet Stud 2010;7:293-302. [PMID: 21713317 DOI: 10.1900/RDS.2010.7.293] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
45 Saha S, Gerdtham UG, Johansson P. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health 2010;7:3150-95. [PMID: 20948954 DOI: 10.3390/ijerph7083150] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
46 Yardley JE, Alberga A, Kenny GP, Sigal RJ. Lifestyle Issues: Exercise. Textbook of Diabetes 2010. [DOI: 10.1002/9781444324808.ch23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
47 Zohrabian A. Clinical and economic considerations of antiobesity treatment: a review of orlistat. Clinicoecon Outcomes Res 2010;2:63-74. [PMID: 21935315 DOI: 10.2147/ceor.s5101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
48 Chrysant SG. Stopping the cardiovascular disease continuum: Focus on prevention. World J Cardiol 2010; 2(3): 43-49 [PMID: 21160754 DOI: 10.4330/wjc.v2.i3.43] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
49 Tuomilehto J. Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes. Diabetes Care 2009;32 Suppl 2:S189-93. [PMID: 19875550 DOI: 10.2337/dc09-S308] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
50 Bacher H, Shepherd GM, Legler UF. Pharmacological Therapies of Obesity: A Review of Current Treatment Options. Biomolecules and Therapeutics 2009;17:348-52. [DOI: 10.4062/biomolther.2009.17.4.348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Laaksonen D, Niskanen L, Lakka H, Lakka T, Uusitupa M. Epidemiology and treatment of the metabolic syndrome. Annals of Medicine 2009;36:332-46. [DOI: 10.1080/07853890410031849] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
52 Tian H, Song G, Xie H, Zhang H, Tuomilehto J, Hu G. Prevalence of diabetes and impaired fasting glucose among 769792 rural Chinese adults. Diabetes Research and Clinical Practice 2009;84:273-8. [DOI: 10.1016/j.diabres.2009.03.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
53 Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Valle TT, Eriksson JG, Tuomilehto J; Finnish Diabetes Prevention Study Group. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One 2009;4:e5656. [PMID: 19479072 DOI: 10.1371/journal.pone.0005656] [Cited by in Crossref: 124] [Cited by in F6Publishing: 135] [Article Influence: 9.5] [Reference Citation Analysis]
54 Yang W. Mission: halt diabetes momentum and stop growing epidemic: . Chinese Medical Journal 2008;121:2115-8. [DOI: 10.1097/00029330-200811010-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Nomura T, Yoshimoto Y, Akezaki Y, Sato A. Changing behavioral patterns to promote physical activity with motivational signs. Environ Health Prev Med 2009;14:20-5. [PMID: 19568864 DOI: 10.1007/s12199-008-0053-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
56 Martin S. Blutglukoseselbstkontrolle zum Selbstmanagement bei Typ-2-Diabetes. Diabetologe 2008;4:457-466. [DOI: 10.1007/s11428-008-0278-8] [Reference Citation Analysis]
57 Nilsson P, Berglund G. Prevention of cardiovascular disease and diabetes: lessons from the Malmö Preventive Project. Journal of Internal Medicine 2008;248:455-462. [DOI: 10.1111/j.1365-2796.2000.00766.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Hewitt JA, Whyte GP, Moreton M, van Someren KA, Levine TS. The effects of a graduated aerobic exercise programme on cardiovascular disease risk factors in the NHS workplace: a randomised controlled trial. J Occup Med Toxicol 2008;3:7. [PMID: 18307781 DOI: 10.1186/1745-6673-3-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
59 Chrysant SG. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum. Clinical Therapeutics 2008;30:2181-90. [DOI: 10.1016/j.clinthera.2008.12.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
60 Kiningham R, Master-hunter T, Kumagai AK. Exercise and Fitness. Clinical Men's Health 2008. [DOI: 10.1016/b978-141603000-3.10021-8] [Reference Citation Analysis]
61 Steinberg BA, Cannon CP. Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential. Am J Cardiol 2007;100:27P-32P. [PMID: 18154743 DOI: 10.1016/j.amjcard.2007.10.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
62 Telford RD. Low physical activity and obesity: causes of chronic disease or simply predictors? Med Sci Sports Exerc 2007;39:1233-40. [PMID: 17762355 DOI: 10.1249/mss.0b013e31806215b7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
63 Rowley KG, Daniel M, Skinner K, Skinner M, White GA, O'dea K. Effectiveness of a community-directed ‘healthy lifestyle’ program in a remote Australian Aboriginal community. Australian and New Zealand Journal of Public Health 2000;24:136-44. [DOI: 10.1111/j.1467-842x.2000.tb00133.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 135] [Article Influence: 9.4] [Reference Citation Analysis]
64 Bobbert, Spranger J. Oligomeric Composition of Adiponectin and Obesity. Oxidative Stress and Disease 2007. [DOI: 10.1201/9781420043792.ch10] [Reference Citation Analysis]
65 Nield L, Moore HJ, Hooper L, Cruickshank JK, Vyas A, Whittaker V, Summerbell CD. Dietary advice for treatment of type 2 diabetes mellitus in adults. Cochrane Database Syst Rev 2007;:CD004097. [PMID: 17636747 DOI: 10.1002/14651858.CD004097.pub4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 51] [Article Influence: 1.9] [Reference Citation Analysis]
66 Kjos SL. After Pregnancy Complicated by Diabetes: Postpartum Care and Education. Obstetrics and Gynecology Clinics of North America 2007;34:335-49. [DOI: 10.1016/j.ogc.2007.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
67 Sato Y, Nagasaki M, Kubota M, Uno T, Nakai N. Clinical aspects of physical exercise for diabetes/metabolic syndrome. Diabetes Res Clin Pract 2007;77 Suppl 1:S87-91. [PMID: 17498834 DOI: 10.1016/j.diabres.2007.01.039] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 3.0] [Reference Citation Analysis]
68 Zimmer P, Halle M. Bewegungsanpassung in der Prävention des Diabetes mellitus Typ 2. Diabetologe 2007;3:113-119. [DOI: 10.1007/s11428-007-0119-1] [Reference Citation Analysis]
69 Samuel-hodge CD, Hill-briggs F, Gary TL. Lifestyle Intervention for Prevention and Treatment of Type 2 Diabetes. Nursing Clinics of North America 2006;41:567-88. [DOI: 10.1016/j.cnur.2006.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
70 Martin S. Risikomanagement bei Typ-2-Diabetes durch Blutzuckerselbstkontrolle. Diabetologe 2006;2:493-501. [DOI: 10.1007/s11428-006-0078-y] [Reference Citation Analysis]
71 Pitsavos C, Panagiotakos D, Weinem M, Stefanadis C. Diet, exercise and the metabolic syndrome. Rev Diabet Stud. 2006;3:118-126. [PMID: 17487335 DOI: 10.1900/rds.2006.3.118] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 6.4] [Reference Citation Analysis]
72 Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project. J Intern Med 2006;260:134-41. [PMID: 16882277 DOI: 10.1111/j.1365-2796.2006.01671.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
73 Frier B, Yang P, Taylor AW. Diabetes, aging and physical activity. Eur Rev Aging Phys Act 2006;3. [DOI: 10.1007/s11556-006-0010-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
74 Colagiuri R, Colagiuri S, Yach D, Pramming S. The answer to diabetes prevention: science, surgery, service delivery, or social policy? Am J Public Health 2006;96:1562-9. [PMID: 16873751 DOI: 10.2105/AJPH.2005.067587] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
75 Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006;16 Suppl 1:3-63. [PMID: 16451303 DOI: 10.1111/j.1600-0838.2006.00520.x] [Cited by in Crossref: 775] [Cited by in F6Publishing: 813] [Article Influence: 48.4] [Reference Citation Analysis]
76 Zanella MT, Uehara MH, Ribeiro AB, Bertolami M, Falsetti AC, Yunes MA. Orlistat and cardiovascular risk profile in hypertensive patients with metabolic syndrome: the ARCOS study. Arq Bras Endocrinol Metabol 2006;50:368-76. [PMID: 16767303 DOI: 10.1590/s0004-27302006000200023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
77 Gelfand EV, Cannon CP. Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors. Journal of the American College of Cardiology 2006;47:1919-26. [DOI: 10.1016/j.jacc.2005.12.067] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 5.1] [Reference Citation Analysis]
78 Gelfand EV, Cannon CP. Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors. Expert Opin Investig Drugs. 2006;15:307-315. [PMID: 16503766 DOI: 10.1517/13543784.15.3.307] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
79 Lyra R, Oliveira M, Lins D, Cavalcanti N. Prevenção do diabetes mellitus tipo 2. Arq Bras Endocrinol Metab 2006;50:239-49. [DOI: 10.1590/s0004-27302006000200010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
80 Sartorelli DS, Franco LJ, Cardoso MA. Intervenção nutricional e prevenção primária do diabetes mellitus tipo 2: uma revisão sistemática. Cad Saúde Pública 2006;22:7-18. [DOI: 10.1590/s0102-311x2006000100002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
81 Van Gaal LF, Mertens IL, Ballaux D. What is the relationship between risk factor reduction and degree of weight loss? European Heart Journal Supplements 2005;7:L21-6. [DOI: 10.1093/eurheartj/sui082] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 4.3] [Reference Citation Analysis]
82 Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol (1985). 2005;99:1193-1204. [PMID: 16103522 DOI: 10.1152/japplphysiol.00160.2005] [Cited by in Crossref: 421] [Cited by in F6Publishing: 462] [Article Influence: 24.8] [Reference Citation Analysis]
83 Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005;118:939-47. [PMID: 16164876 DOI: 10.1016/j.amjmed.2005.05.018] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
84 Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21. [PMID: 16012941 DOI: 10.1053/j.gastro.2005.04.014] [Cited by in Crossref: 2074] [Cited by in F6Publishing: 2179] [Article Influence: 122.0] [Reference Citation Analysis]
85 Roberts CK, Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol (1985) 2005;98:3-30. [PMID: 15591300 DOI: 10.1152/japplphysiol.00852.2004] [Cited by in Crossref: 317] [Cited by in F6Publishing: 334] [Article Influence: 18.6] [Reference Citation Analysis]
86 Cameron A, Shaw J, Zimmet P. The Metabolic Syndrome. The Metabolic Syndrome at the Beginning of the XXI Century 2005. [DOI: 10.1016/b978-84-8174-892-5.50028-0] [Reference Citation Analysis]
87 Yang Y. Exercise in Diabetes Mellitus. J Korean Med Assoc 2005;48:822. [DOI: 10.5124/jkma.2005.48.9.822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Ahren B, Pacini G. Islet adaptation to insulin resistance: mechanisms and implications for intervention. Diabetes Obes Metab 2005;7:2-8. [DOI: 10.1111/j.1463-1326.2004.00361.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 3.4] [Reference Citation Analysis]
89 Davies MJ, Tringham JR, Troughton J, Khunti KK. Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting. Diabet Med 2004;21:403-14. [PMID: 15089783 DOI: 10.1111/j.1464-5491.2004.01176.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
90 Lindgärde F, Ercilla MB, Correa LR, Ahrén B. Body adiposity, insulin, and leptin in subgroups of Peruvian Amerindians. High Alt Med Biol 2004;5:27-31. [PMID: 15072714 DOI: 10.1089/152702904322963663] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
91 Tripathy D, Eriksson KF, Orho-Melander M, Fredriksson J, Ahlqvist G, Groop L. Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia 2004;47:782-93. [PMID: 15114470 DOI: 10.1007/s00125-004-1393-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 3.1] [Reference Citation Analysis]
92 Palmer AJ, Roze S, Valentine WJ, Spinas GA, Shaw JE, Zimmet PZ. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clinical Therapeutics 2004;26:304-21. [DOI: 10.1016/s0149-2918(04)90029-x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 97] [Article Influence: 4.9] [Reference Citation Analysis]
93 Gaesser GA. Weight Loss for the Obese: Panacea or Pound-Foolish? Quest 2004;56:12-27. [DOI: 10.1080/00336297.2004.10491812] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
94 Kemmer FW. Körperliche Bewegung und Sport in der Behandlung des Diabetes mellitus. Diabetes in der Praxis 2004. [DOI: 10.1007/978-3-642-18571-7_15] [Reference Citation Analysis]
95 Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 2003;24:113-9. [PMID: 14609022 DOI: 10.1023/a:1026070911202] [Cited by in Crossref: 322] [Cited by in F6Publishing: 332] [Article Influence: 16.9] [Reference Citation Analysis]
96 Schernthaner G. Fortschritte in der Prävention des Typ-2-Diabetes. Wien Klin Wochenschr 2003;115:745-57. [DOI: 10.1007/bf03040499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
97 Panzer C, Brieke A, Ruderman N. Prevention of type 2 diabetes and its macrovascular complications: whom, when, and how should we treat?: . Current Opinion in Endocrinology & Diabetes 2003;10:229-36. [DOI: 10.1097/00060793-200308000-00001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
98 Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J Hypertens 2002;20:1879-86. [PMID: 12195132 DOI: 10.1097/00004872-200209000-00035] [Cited by in Crossref: 273] [Cited by in F6Publishing: 282] [Article Influence: 14.4] [Reference Citation Analysis]
99 . Cardiovascular risk profile assessment in glucose-intolerant Asian individuals-an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). The DECODA Study Group on behalf of the International Diabetes Epidemiology Group*. Diabet Med 2002;19:549-57. [DOI: 10.1046/j.1464-5491.2002.00735.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
100 Wylie G, Hungin AP, Neely J. Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ 2002;324:1190. [PMID: 12016185 DOI: 10.1136/bmj.324.7347.1190] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
101 Ozaki K, Okubo M, Mori H, Mito K, Hara H, Kohno N. Decreased insulin secretion and dyslipidemia coexist in subjects with impaired fasting glucose. Diabetes Res Clin Pract 2002;55:159-64. [PMID: 11796182 DOI: 10.1016/s0168-8227(01)00315-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
102 Harmel AP. Considerations for treating dyslipidemia in special diabetic populations. Diabetes Metab Res Rev 2002;18:88-95. [PMID: 11994899 DOI: 10.1002/dmrr.270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
103 Goday A, Delgado E, Díaz Cadórniga F, De Pablos P, Vázquez J, Soto E. Epidemiología de la diabetes tipo 2 en España. Endocrinología y Nutrición 2002;49:113-26. [DOI: 10.1016/s1575-0922(02)74441-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
104 Goday A. Epidemiología de la diabetes y sus complicaciones no coronaries. Revista Española de Cardiología 2002;55:657-70. [DOI: 10.1016/s0300-8932(02)76674-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
105 Li C, Tsai S, Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment. Journal of Clinical Epidemiology 2002;55:19-24. [DOI: 10.1016/s0895-4356(01)00410-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
106 Berne C. Diabetes mellitus - a more solid ground for treatment. J Intern Med 2001;249:391-393. [DOI: 10.1046/j.1365-2796.2001.00836.x] [Reference Citation Analysis]
107 Rolandsson O, Hägg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A. Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 2001;249:279-88. [PMID: 11298847 DOI: 10.1046/j.1365-2796.2001.00813.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
108 Swinburn BA, Metcalf PA, Ley SJ. Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 2001;24:619-24. [PMID: 11315819 DOI: 10.2337/diacare.24.4.619] [Cited by in Crossref: 155] [Cited by in F6Publishing: 165] [Article Influence: 7.4] [Reference Citation Analysis]
109 Laredo S, Hannah ME, Casper R, Feig D, Leiter L, Rodgers CD. Polycystic Ovary Syndrome and Insulin Resistance: New Approaches to Management, including Exercise. Journal SOGC 2001;23:306-312. [DOI: 10.1016/s0849-5831(16)31301-5] [Reference Citation Analysis]
110 Bloomgarden ZT. American Diabetes Association 60th Scientific Sessions, 2000: Cardiovascular disease in diabetes. Diabetes Care 2001;24:399-404. [DOI: 10.2337/diacare.24.2.399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
111 Reeder BA. National and International Strategies to Prevent Obesity and Diabetes. Diabetes and Cardiovascular Disease 2001. [DOI: 10.1007/978-1-4615-1321-6_51] [Reference Citation Analysis]
112 Nilsson P, Berglund G. Prevention of cardiovascular disease and diabetes: lessons from the Malmo Preventive Project. J Intern Med 2000;248:455-62. [DOI: 10.1046/j.1365-2796.2000.00766.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
113 Anwaar I, Gottsäter A, Eriksson K, Jacobsson L, Lindgärde F, Mattiasson I. Increased plasma endothelin-1 and intraplatelet cyclic guanosine monophosphate in men with disturbed glucose metabolism. Diabetes Res Clin Pract 2000;50:127-36. [PMID: 10960723 DOI: 10.1016/s0168-8227(00)00190-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
114 Yeater R. Obesity, Metabolic Syndrome, and Physical Activity. Quest 2000;52:351-7. [DOI: 10.1080/00336297.2000.10491722] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
115 Lindgarde F. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study. J Intern Med 2000;248:245-54. [DOI: 10.1046/j.1365-2796.2000.00720.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 149] [Article Influence: 6.1] [Reference Citation Analysis]
116 Kjos SL. Postpartum care of the woman with diabetes. Clin Obstet Gynecol 2000;43:75-86. [PMID: 10694990 DOI: 10.1097/00003081-200003000-00008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
117 Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, Lindgärde F. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 2000;247:19-29. [PMID: 10672127 DOI: 10.1046/j.1365-2796.2000.00568.x] [Cited by in Crossref: 179] [Cited by in F6Publishing: 181] [Article Influence: 8.1] [Reference Citation Analysis]
118 Grimm JJ. Interaction of physical activity and diet: implications for insulin-glucose dynamics. Public Health Nutr 1999;2:363-8. [PMID: 10610074 DOI: 10.1017/s136898009900049x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
119 Antonio Vázquez J, Gaztambide S, Soto-pedre E. Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2. Medicina Clínica 2000;115:534-9. [DOI: 10.1016/s0025-7753(00)71616-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
120 Peirce NS. Diabetes and exercise. Br J Sports Med 1999;33:161-72; quiz 172-3, 222. [PMID: 10378067 DOI: 10.1136/bjsm.33.3.161] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 2.9] [Reference Citation Analysis]
121 Florkowski CM, Scott RS. Type 2 diabetes towards the new millennium--the relative importance of glycaemic versus lipid control. Aust N Z J Med 1999;29:249-53. [PMID: 10342026 DOI: 10.1111/j.1445-5994.1999.tb00692.x] [Reference Citation Analysis]